• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comorbid mood disorders and medical illness: a Food and Drug Administration perspective.

作者信息

Laughren Thomas P

机构信息

Food and Drug Administration (HFD-120), 1451 Rockville Pike, Rockville, MD 20857, USA.

出版信息

Biol Psychiatry. 2003 Aug 1;54(3):195-9. doi: 10.1016/s0006-3223(03)00529-8.

DOI:10.1016/s0006-3223(03)00529-8
PMID:12893095
Abstract
摘要

相似文献

1
Comorbid mood disorders and medical illness: a Food and Drug Administration perspective.共病情绪障碍与躯体疾病：美国食品药品监督管理局的观点
Biol Psychiatry. 2003 Aug 1;54(3):195-9. doi: 10.1016/s0006-3223(03)00529-8.
2
Thinking outside the (black) box: antidepressants, suicidality, and research synthesis.跳出（黑）框框思考：抗抑郁药、自杀倾向与研究综述
Pediatrics. 2005 Jul;116(1):231-3. doi: 10.1542/peds.2005-1041.
3
Adolescent psychopharmacology: drugs for mood disorders.青少年精神药理学：用于情绪障碍的药物
Adolesc Med Clin. 2006 Oct;17(3):789-808; abstract xiii-xiv. doi: 10.1016/j.admecli.2006.06.003.
4
[Cognitive deficits in depression].[抑郁症中的认知缺陷]
Duodecim. 2004;120(14):1738-44.
5
Comorbidity of mental retardation and affective disorders.智力发育迟缓与情感障碍的共病。
J Indian Med Assoc. 2000 May;98(5):245, 248-9.
6
Current and future therapeutic opportunities in the comorbidity between the epilepsies and affective disorders.癫痫与情感障碍共病的当前及未来治疗机遇
Clin EEG Neurosci. 2004 Jan;35(1):1-3. doi: 10.1177/155005940403500106.
7
Affective illness and epilepsy.情感性疾病与癫痫
J Clin Psychiatry. 1997 Nov;58(11):498-9. doi: 10.4088/jcp.v58n1106f.
8
The recognition and management of mood disorders as a comorbidity of epilepsy.将情绪障碍作为癫痫的一种共病进行识别与管理。
Epilepsia. 2003;44 Suppl 4:30-40. doi: 10.1046/j.1528-1157.44.s4.4.x.
9
Recognizing and meeting the needs of patients with mood disorders and comorbid medical illness: a consensus conference of the Depression and Bipolar Support Alliance.识别并满足患有情绪障碍及合并躯体疾病患者的需求：抑郁与双相情感障碍支持联盟共识会议
Biol Psychiatry. 2003 Aug 1;54(3):181-3. doi: 10.1016/s0006-3223(03)00567-5.
10
Life events, medical comorbidity, and somatic symptoms in pediatric mood disorders.儿童情绪障碍中的生活事件、共病情况和躯体症状。
J Clin Psychiatry. 2009 Oct;70(10):1439-40. doi: 10.4088/JCP.09f05642gre.

引用本文的文献

1
US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer's Disease: Implications for Global Drug Development.美国、欧盟和日本治疗阿尔茨海默病药物开发的监管指南：对全球药物开发的影响。
Clin Transl Sci. 2020 Jul;13(4):652-664. doi: 10.1111/cts.12755. Epub 2020 Mar 3.
2
KETAMINE: A POTENTIAL RAPID-ACTING ANTISUICIDAL AGENT?氯胺酮：一种潜在的速效抗自杀药物？
Depress Anxiety. 2016 Aug;33(8):711-7. doi: 10.1002/da.22498. Epub 2016 Apr 15.
3
Measuring anxiety as a treatment endpoint in youth with autism spectrum disorder.
将焦虑作为自闭症谱系障碍青少年的治疗终点进行测量。
J Autism Dev Disord. 2014 May;44(5):1128-43. doi: 10.1007/s10803-013-1974-9.
4
Medical problems among adolescents in U.S. mental health services: relationship to functional impairment.
J Behav Health Serv Res. 2006 Jul;33(3):366-79. doi: 10.1007/s11414-006-9022-6.
5
Principles for evidence-based drug formulary policy.循证药物处方集政策原则。
J Gen Intern Med. 2005 Oct;20(10):964-8. doi: 10.1111/j.1525-1497.2005.0232.x.
6
Food and Drug Administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim.美国食品药品监督管理局对精神分裂症阴性症状作为药物治疗宣称靶点的看法。
Schizophr Bull. 2006 Apr;32(2):220-2. doi: 10.1093/schbul/sbi039. Epub 2005 Aug 3.